Connection

Giovanna Lunghi to Drug Therapy, Combination

Back to Details
This is a "connection" page, showing publications Giovanna Lunghi has written about Drug Therapy, Combination.
Giovanna Lunghi
Connection Strength
0.052
Drug Therapy, Combination
  1. Excellent safety and effectiveness of high-dose myrcludex-B monotherapy administered for 48 weeks in HDV-related compensated cirrhosis: A case report of 3 patients. J Hepatol. 2019 10; 71(4):834-839.
    View in: PubMed
    Score: 0.018
  2. Lamivudine prophylaxis prevents hepatitis B virus reactivation in anti-HBc positive patients under rituximab for non-Hodgkin lymphoma. Dig Liver Dis. 2019 03; 51(3):419-424.
    View in: PubMed
    Score: 0.017
  3. 12 weeks ombitasvir/paritaprevir-ritonavir + ribavirin achieve high SVR rates in HCV-4 patients with advanced fibrosis. Dig Liver Dis. 2018 07; 50(7):703-706.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.